Prosight Management
Latest statistics and disclosures from Prosight Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PRCT, GLPG, JANX, ADCT, KURA, and represent 34.67% of Prosight Management's stock portfolio.
- Added to shares of these 10 stocks: PRCT (+$41M), NKTR (+$23M), JANX (+$21M), VEEV (+$20M), PHR (+$17M), BSX (+$13M), AVTR (+$10M), LH (+$8.7M), WGS (+$7.2M), ALNY (+$6.8M).
- Started 11 new stock positions in ACET, AVTR, ABVX, TERN, LH, ALNY, NKTR, WGS, VEEV, TEM. PHR.
- Reduced shares in these 10 stocks: , BBIO (-$18M), ROIV (-$15M), DXCM (-$13M), CORCEPT THERAPEUTICS INC COMMON Stock cmn (-$12M), IMVT (-$12M), STTK (-$11M), BHVN (-$9.0M), , FOLD (-$8.0M).
- Sold out of its positions in ACHC, ACTU, AKRO, ALGN, ARGX, CORCEPT THERAPEUTICS INC COMMON Stock cmn, CTMX, DXCM, ISRG, SDGR. SGHT, TWST, VRTX, BHVN, PRTA.
- Prosight Management was a net buyer of stock by $9.4M.
- Prosight Management has $484M in assets under management (AUM), dropping by 12.86%.
- Central Index Key (CIK): 0001617201
Tip: Access up to 7 years of quarterly data
Positions held by Prosight Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Prosight Management
Prosight Management holds 38 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Procept Biorobotics Corp (PRCT) | 9.0 | $43M | +1692% | 1.4M | 31.46 |
|
| Galapagos Nv Spon Adr (GLPG) | 7.3 | $35M | -6% | 1.1M | 32.70 |
|
| Janux Therapeutics (JANX) | 6.8 | $33M | +176% | 2.4M | 13.80 |
|
| Adc Therapeutics Sa SHS (ADCT) | 6.2 | $30M | +13% | 8.5M | 3.53 |
|
| Kura Oncology (KURA) | 5.4 | $26M | -8% | 2.5M | 10.39 |
|
| Meiragtx Holdings (MGTX) | 5.3 | $26M | -21% | 3.2M | 7.95 |
|
| Nektar Therapeutics Com New (NKTR) | 4.8 | $23M | NEW | 555k | 42.28 |
|
| Veeva Sys Cl A Com (VEEV) | 4.2 | $20M | NEW | 90k | 223.23 |
|
| Icon SHS (ICLR) | 4.1 | $20M | 110k | 182.22 |
|
|
| Boston Scientific Corporation (BSX) | 4.1 | $20M | +175% | 210k | 95.35 |
|
| Concentra Group Holdings Par Common Stock (CON) | 3.6 | $18M | +46% | 891k | 19.68 |
|
| Phreesia (PHR) | 3.4 | $17M | NEW | 977k | 16.92 |
|
| Amicus Therapeutics (FOLD) | 3.4 | $16M | -32% | 1.2M | 14.24 |
|
| Select Medical Holdings Corporation (SEM) | 3.2 | $15M | +18% | 1.0M | 14.85 |
|
| Syndax Pharmaceuticals (SNDX) | 2.9 | $14M | -33% | 665k | 21.01 |
|
| Zymeworks Del (ZYME) | 2.9 | $14M | -29% | 530k | 26.33 |
|
| Roivant Sciences SHS (ROIV) | 2.8 | $14M | -53% | 627k | 21.70 |
|
| Crinetics Pharmaceuticals In (CRNX) | 2.5 | $12M | -20% | 263k | 46.55 |
|
| Avantor (AVTR) | 2.1 | $10M | NEW | 899k | 11.46 |
|
| Shattuck Labs (STTK) | 1.8 | $8.7M | -56% | 2.4M | 3.65 |
|
| Labcorp Holdings Com Shs (LH) | 1.8 | $8.7M | NEW | 35k | 250.88 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 1.5 | $7.2M | NEW | 55k | 130.06 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.4 | $6.8M | NEW | 17k | 397.65 |
|
| Immunovant (IMVT) | 1.3 | $6.2M | -65% | 243k | 25.42 |
|
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.2 | $5.6M | +99% | 684k | 8.14 |
|
| Tectonic Therapeutic (TECX) | 1.0 | $4.9M | -38% | 235k | 20.86 |
|
| Caredx (CDNA) | 1.0 | $4.7M | -50% | 250k | 18.84 |
|
| Terns Pharmaceuticals (TERN) | 0.8 | $3.8M | NEW | 95k | 40.40 |
|
| Rocket Pharmaceuticals (RCKT) | 0.5 | $2.6M | -41% | 744k | 3.51 |
|
| Orthopediatrics Corp. (KIDS) | 0.5 | $2.4M | -55% | 137k | 17.76 |
|
| Onkure Therapeutics Com Cl A (OKUR) | 0.5 | $2.4M | +204% | 817k | 2.90 |
|
| Bridgebio Pharma (BBIO) | 0.5 | $2.3M | -88% | 30k | 76.49 |
|
| Abivax Sa Sponsored Ads (ABVX) | 0.5 | $2.3M | NEW | 17k | 134.85 |
|
| Adicet Bio Com New (ACET) | 0.4 | $2.1M | NEW | 250k | 8.42 |
|
| Tempus Ai Cl A (TEM) | 0.4 | $2.1M | NEW | 35k | 59.05 |
|
| TrueBlue (TBI) | 0.4 | $2.0M | +456% | 443k | 4.55 |
|
| Pliant Therapeutics (PLRX) | 0.4 | $1.9M | +7493% | 1.6M | 1.22 |
|
| Rein Therapeutics Com New (RNTX) | 0.1 | $513k | -22% | 443k | 1.16 |
|
Past Filings by Prosight Management
SEC 13F filings are viewable for Prosight Management going back to 2017
- Prosight Management 2025 Q4 filed Feb. 13, 2026
- Prosight Management 2025 Q3 filed Nov. 14, 2025
- Prosight Management 2025 Q2 filed Aug. 14, 2025
- Prosight Management 2025 Q1 filed May 15, 2025
- Prosight Management 2024 Q4 filed Feb. 14, 2025
- Prosight Management 2024 Q3 filed Nov. 14, 2024
- Prosight Management 2024 Q2 filed Aug. 14, 2024
- Prosight Management 2024 Q1 filed May 15, 2024
- Prosight Management 2023 Q3 filed Nov. 14, 2023
- Prosight Management 2023 Q2 filed Aug. 14, 2023
- Prosight Management 2023 Q2 restated filed Aug. 14, 2023
- Prosight Management 2023 Q1 filed May 12, 2023
- Prosight Management 2022 Q4 filed Feb. 14, 2023
- Prosight Management 2022 Q3 filed Nov. 14, 2022
- Prosight Management 2022 Q2 filed Aug. 12, 2022
- Prosight Management 2022 Q1 filed May 16, 2022